Clinical trial
Aspirin Prophylaxis in Sickle Cell Disease
NCT00178464 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00178464 |
|---|---|
| Title | Aspirin Prophylaxis in Sickle Cell Disease |
| Official title | Aspirin Prophylaxis in Sickle Cell Disease |
| Acronym | START |
| Lead sponsor | University of Rochester, Other |
| Collaborators | University of Miami Bayer Industry National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sickle Cell Disease |
| Intervention type | Drug |
| Interventions | aspirin |
| Enrollment | 11 |
| Start date | Mar 1, 2005 |
| Primary completion | Apr 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 6, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: